Naseem Amin

Insider Reports History

Entity
Individual
Location
53 Frontage Road, Suite 301, Hampton, NJ
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Naseem Amin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AVADEL PHARMACEUTICALS PLC Director Ordinary Shares 11K $112K $10.19 Jul 30, 2024 Direct
Bellerophon Therapeutics, Inc. Director Common Stock 292K $30.3K $0.10 Jun 7, 2023 Direct
AVADEL PHARMACEUTICALS PLC Director Stock Option (Right to Buy) 11K Jul 30, 2024 Direct

Insider Reports Filed by Naseem Amin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVDL AVADEL PHARMACEUTICALS PLC Jul 30, 2024 2 $0 4 Aug 1, 2024 Director
AVDL AVADEL PHARMACEUTICALS PLC May 17, 2024 1 $0 4 May 21, 2024 Director
AVDL AVADEL PHARMACEUTICALS PLC May 17, 2024 0 $0 3 May 21, 2024 Director
BLPH Bellerophon Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
BLPH Bellerophon Therapeutics, Inc. Feb 10, 2023 1 $0 4 Feb 14, 2023 Director
BLPH Bellerophon Therapeutics, Inc. Dec 31, 2021 2 $26.9K 4 Jan 4, 2022 Director